Capital Fund Management (CFM)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Capital Fund Management (CFM)’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-581,359	Closed	-$2.4M	–	2140
2024 Q3	$2.4M	Buy	581,359 +275,738	+90%	+$1.48M	0.01%	1347
2024 Q2	$1.99M	Buy	+305,621	New	+$2.16M	0.01%	1384
2023 Q2	–	Sell	-38,646	Closed	-$407K	–	1782
2023 Q1	$407K	Sell	38,646 -275,902	-88%	-$3.09M	﹤0.01%	1470
2022 Q4	$3.9M	Buy	314,548 +67,563	+27%	+$766K	0.03%	708
2022 Q3	$2.56M	Buy	246,985 +127,532	+107%	+$1.45M	0.02%	784
2022 Q2	$1.38M	Buy	119,453 +43,399	+57%	+$511K	0.01%	955
2022 Q1	$957K	Buy	76,054 +35,630	+88%	+$408K	0.01%	1162
2021 Q4	$471K	Sell	40,424 -1,913	-5%	-$23.5K	﹤0.01%	1453
2021 Q3	$553K	Buy	42,337 +5,214	+14%	+$67.4K	﹤0.01%	1352
2021 Q2	$478K	Buy	37,123 +15,831	+74%	+$181K	﹤0.01%	1308
2021 Q1	$238K	Sell	21,292 -7,445	-26%	-$78.6K	﹤0.01%	1221
2020 Q4	$327K	Buy	+28,737	New	+$314K	﹤0.01%	1198
2019 Q4	–	Sell	-11,100	Closed	-$95K	–	1923
2019 Q3	$95K	Buy	+11,100	New	+$108K	﹤0.01%	1613

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Capital Fund Management (CFM)'s IRWD Position: Q4 2024 in Review

Capital Fund Management (CFM) sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 581,359 shares — an estimated $2.4M sold.

Capital Fund Management (CFM) first reported a position in IRWD in Q3 2019 and held it in 13 quarters. The position peaked at $3.9M in Q4 2022. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

Capital Fund Management (CFM) reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Capital Fund Management (CFM) sold 581,359 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $2.4M.
Capital Fund Management (CFM) first reported a position in Ironwood Pharmaceuticals in Q3 2019 and held it in 13 quarters.
Capital Fund Management (CFM)'s Ironwood Pharmaceuticals position peaked at $3.9M in Q4 2022.
223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2024, filed 13 Feb 2025.